South Koreas Deputy Prime Minister Warns AI Wealth Must Benefit Public Amid Samsung Labor Unrest Perpetua Resources Secures 29 Billion US ExportImport Bank Loan for Idaho Gold and Antimony Project Elon Musk Loses OpenAI Lawsuit Yet Legal Battles Likely to Continue Singapore Refreshed Retail Digital Plan Pushes AI Adoption for Local Retailers Portugals Meo Takes Legal Action Against State Over 82 Million Huawei 5G Ban Market Edges Higher as Healthcare and Tech Rally Offset Communication Weakness FOXF Q1 2026 Earnings EPS Surges Past Estimates Despite Revenue Challenges SIDU Q1 2026 Earnings Space Company Reports Narrowed Loss as Stock Surges 24 KRG Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Holds Steady Silvaco Group Inc Q1 2026 Earnings SmallerThanExpected Loss Drives Positive Stock Reaction U Q1 2026 Earnings NarrowerThanExpected Loss Drives Shares Higher GDS Holdings Q1 2026 Earnings Stunning EPS Beat of 132 vs Expected Loss Phoenix Asia Holdings PHOE Edges Higher as Key Resistance Nears ITT Inc ITT Surges 3 Breaking Out Toward Resistance Amid Strong Momentum United Community Banks UCB Edges Lower Amid Consolidation Near Key Support Evolution Global Acquisition Corp EVOX Holds Steady at 1000 Near NAV Stasis Preferred Bank PFBC Holds Steady Near 9469 as Support and Resistance Levels Come into Focus Walmart to Use Tariff Refunds for Price Cuts as Consumer Stress Rises JBTM Q1 2026 Earnings EPS Beat Drives Positive Market Reaction AiRWA Inc YYAI Faces Mild Pullback Amid Sector Rotation Key Support Tested PXLW Q1 2026 Earnings Massive EPS Surprise of 8825 as Company Reports 1246 vs 014 Estimate Rigetti Computing Inc RGTI Q1 2026 Earnings NarrowerThanExpected Loss as Quantum Computing Firm Prepares for Commercial Scale Western Midstream Partners Q1 2026 Earnings EPS Beats Estimates by 1391 Stock Rises HERE Q4 2025 Earnings Massive EPS Surprise Masks Underlying Concerns Jiayin Group Inc Q4 2024 Earnings EPS of 523 Reported Stock Declines 87 HIG Q1 2026 Earnings EPS Misses Estimates by 10 Stock Unchanged Amid Mixed Signals Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development